Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2020

Open Access 01-08-2020 | Public Health | Research Article

Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications

Authors: Qamar Niaz, Brian Godman, Stephen Campbell, Dan Kibuule

Published in: International Journal of Clinical Pharmacy | Issue 4/2020

Login to get access

Abstract

Background The World Health Organization estimates that over 50% medicines are prescribed inappropriately and the main driver of antimicrobial resistance globally. There have only been a limited number of studies evaluating prescribing patterns against national standard treatment guidelines (STGs) in sub-Saharan African countries including Namibia. This is important given the high prevalence of both infectious and non-infectious diseases in sub-Saharan Africa alongside limited resources. Objective Our aim was to assess prescribing practices and drivers of compliance to National guidelines among public health care facilities in Namibia to provide future guidance. Setting Three levels of public healthcare in Namibia. Method A mixed method approach including patient exit and prescriber interviews at three levels of health care in Namibia, i.e. hospital, health centre and clinic. Main outcome measures Medicine prescribing indicators, compliance to and attitudes towards National guidelines. Results Of the 1243 prescriptions analysed, 73% complied with the STGs and 69% had an antibiotic. Of the 3759 medicines (i.e. mean of 3.0 ± 1.1) prescribed, 64% were prescribed generically. The vast majority of prescribers were aware of, and had access to, the Namibian STGs (94.6%), with the majority reporting that the guidelines are easy to use and they regularly refer to them. The main drivers of compliance to guidelines were programmatic, that is access to up-to date objective guidelines, support systems for continued education on their use, and ease of referencing. Lack of systems to regulate noncompliance impacted on their use. Conclusion Whilst the findings were encouraging, ongoing concerns included limited prescribing of generic medicines and high use of antibiotics. A prescribing performance management system should be introduced to improve and monitor compliance to prescribing guidelines in public healthcare.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9.CrossRefPubMed Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9.CrossRefPubMed
3.
go back to reference Lates J, Shiyandja N. Third National Survey on the use of drugs in Namibia’s public health institutions including monitoring the implementation of the National Drug Policy. Windhoek, Namibia: Ministry of Health and Social Services; 2001. Lates J, Shiyandja N. Third National Survey on the use of drugs in Namibia’s public health institutions including monitoring the implementation of the National Drug Policy. Windhoek, Namibia: Ministry of Health and Social Services; 2001.
5.
go back to reference Nashilongo MM, Singu B, Kalemeera F, Mubita M, Naikaku E, Baker A, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–78.CrossRefPubMedPubMedCentral Nashilongo MM, Singu B, Kalemeera F, Mubita M, Naikaku E, Baker A, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–78.CrossRefPubMedPubMedCentral
7.
go back to reference Kibuule D, Verbeeck RK, Nunurai R, Mavhunga F, Ene E, Godman B, et al. Predictors of tuberculosis treatment success under the DOTS program in Namibia. Expert Rev Respir Med. 2018;12(11):979–87.CrossRefPubMed Kibuule D, Verbeeck RK, Nunurai R, Mavhunga F, Ene E, Godman B, et al. Predictors of tuberculosis treatment success under the DOTS program in Namibia. Expert Rev Respir Med. 2018;12(11):979–87.CrossRefPubMed
8.
go back to reference Mataranyika PA, Kibuule D, Kalemeera F, Kaura H, Godman B, Rennie WT. Liver enzyme elevations in a cohort of HIV/AIDS patients on first-line antiretroviral therapy in Namibia: findings and implications. Alex J Med. 2018;54:49–56.CrossRef Mataranyika PA, Kibuule D, Kalemeera F, Kaura H, Godman B, Rennie WT. Liver enzyme elevations in a cohort of HIV/AIDS patients on first-line antiretroviral therapy in Namibia: findings and implications. Alex J Med. 2018;54:49–56.CrossRef
9.
go back to reference Niaz Q, Godman B, Massele A, Campbell S, Kurdi A, Kagoya HR, et al. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications. Int J Qual Health Care. 2019;31(5):338–45.CrossRefPubMed Niaz Q, Godman B, Massele A, Campbell S, Kurdi A, Kagoya HR, et al. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications. Int J Qual Health Care. 2019;31(5):338–45.CrossRefPubMed
10.
go back to reference Nakwatumbah S, Kibuule D, Godman B, Haakuria V, Kalemeera F, Baker A, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–21.CrossRefPubMed Nakwatumbah S, Kibuule D, Godman B, Haakuria V, Kalemeera F, Baker A, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–21.CrossRefPubMed
15.
go back to reference Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16:724.CrossRefPubMedPubMedCentral Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16:724.CrossRefPubMedPubMedCentral
16.
go back to reference Machingaidze S, Grimmer K, Louw Q, Kredo T, Young T, Volmink J. Next generation clinical guidance for primary care in South Africa: credible, consistent and pragmatic. PLoS ONE. 2018;13(3):e0195025.CrossRefPubMedPubMedCentral Machingaidze S, Grimmer K, Louw Q, Kredo T, Young T, Volmink J. Next generation clinical guidance for primary care in South Africa: credible, consistent and pragmatic. PLoS ONE. 2018;13(3):e0195025.CrossRefPubMedPubMedCentral
17.
go back to reference Massele A, Tiroyakgosi C, Matome M, Desta A, Muller A, Paramadhas BD, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):1–4.CrossRefPubMed Massele A, Tiroyakgosi C, Matome M, Desta A, Muller A, Paramadhas BD, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):1–4.CrossRefPubMed
18.
go back to reference van der Sandt N, Schellack N, Mabope LA, Mawela MPB, Kruger D, Godman B. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settings. Pediatr Infect Dis J. 2019;38(2):122–6.CrossRefPubMed van der Sandt N, Schellack N, Mabope LA, Mawela MPB, Kruger D, Godman B. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settings. Pediatr Infect Dis J. 2019;38(2):122–6.CrossRefPubMed
19.
go back to reference Meyer JC, Schellack N, Stokes J, Lancaster R, Zeeman H, Defty D, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africal; A preliminary study. Front Pharmacol. 2017;8:751.CrossRefPubMedPubMedCentral Meyer JC, Schellack N, Stokes J, Lancaster R, Zeeman H, Defty D, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africal; A preliminary study. Front Pharmacol. 2017;8:751.CrossRefPubMedPubMedCentral
21.
go back to reference Ismail N, Ismail F, Omar SV, Blows L, Gardee Y, Koornhof H, et al. Drug resistant tuberculosis in Africa: current status, gaps and opportunities. Afr J Lab Med. 2018;7(2):781.CrossRefPubMedPubMedCentral Ismail N, Ismail F, Omar SV, Blows L, Gardee Y, Koornhof H, et al. Drug resistant tuberculosis in Africa: current status, gaps and opportunities. Afr J Lab Med. 2018;7(2):781.CrossRefPubMedPubMedCentral
22.
go back to reference Ansah EK, Narh-Bana S, Affran-Bonful H, Bart-Plange C, Cundill B, Gyapong M, et al. The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial. BMJ. 2015;350:h1019.CrossRefPubMedPubMedCentral Ansah EK, Narh-Bana S, Affran-Bonful H, Bart-Plange C, Cundill B, Gyapong M, et al. The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial. BMJ. 2015;350:h1019.CrossRefPubMedPubMedCentral
23.
go back to reference Kibuule D, Rennie TW, Ruswa N, Mavhunga F, Thomas A, Amutenya R, et al. Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia. Int J Tuberc Lung Dis. 2019;23(4):441–9.CrossRefPubMed Kibuule D, Rennie TW, Ruswa N, Mavhunga F, Thomas A, Amutenya R, et al. Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia. Int J Tuberc Lung Dis. 2019;23(4):441–9.CrossRefPubMed
24.
go back to reference Pastakia SD, Pekny CR, Manyara SM, Fischer L. Diabetes in sub-Saharan Africa: from policy to practice to progress—targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes. 2017;10:247–63.CrossRefPubMedPubMedCentral Pastakia SD, Pekny CR, Manyara SM, Fischer L. Diabetes in sub-Saharan Africa: from policy to practice to progress—targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes. 2017;10:247–63.CrossRefPubMedPubMedCentral
25.
go back to reference Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, Anand Paramadhas BD, et al. Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Front Pharmacol. 2020;11(108). Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, Anand Paramadhas BD, et al. Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Front Pharmacol. 2020;11(108).
26.
go back to reference Torrone EA, Morrison CS, Chen P-L, Kwok C, Francis SC, Hayes RJ, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 2018;15(2):e1002511-e.CrossRef Torrone EA, Morrison CS, Chen P-L, Kwok C, Francis SC, Hayes RJ, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 2018;15(2):e1002511-e.CrossRef
27.
go back to reference Tiroyakgosi C, Matome M, Summers E, Mashalla Y, Paramadhas BA, Souda S, et al. Ongoing initiatives to improve the use of antibiotics in Botswana: University of Botswana symposium meeting report. Expert Rev Anti Infect Ther. 2018;16(5):381–4.CrossRefPubMed Tiroyakgosi C, Matome M, Summers E, Mashalla Y, Paramadhas BA, Souda S, et al. Ongoing initiatives to improve the use of antibiotics in Botswana: University of Botswana symposium meeting report. Expert Rev Anti Infect Ther. 2018;16(5):381–4.CrossRefPubMed
29.
go back to reference Mashalla Y, Setlhare V, Massele A, Sepako E, Tiroyakgosi C, Kgatlwane J, et al. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: findings and implications. Int J Clin Pract. 2017;71(12):e13042.CrossRef Mashalla Y, Setlhare V, Massele A, Sepako E, Tiroyakgosi C, Kgatlwane J, et al. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: findings and implications. Int J Clin Pract. 2017;71(12):e13042.CrossRef
30.
go back to reference Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop Med Int Health. 2013;18(6):656–64.CrossRefPubMed Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop Med Int Health. 2013;18(6):656–64.CrossRefPubMed
31.
go back to reference Matsitse TB, Helberg E, Meyer JC, Godman B, Massele A, Schellack N. Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev Anti Infect Ther. 2017;15(10):963–72.CrossRefPubMed Matsitse TB, Helberg E, Meyer JC, Godman B, Massele A, Schellack N. Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev Anti Infect Ther. 2017;15(10):963–72.CrossRefPubMed
32.
go back to reference Mashalla YJ, Sepako E, Setlhare V, Chuma M, Bulang M, Massele AY. Availability of guidelines and policy documents for enhancing performance of practitioners at the Primary Health Care (PHC) facilities in Gaborone, Tlokweng and Mogoditshane, Republic of Botswana. J Public Health Epidemiol. 2016;8(8):127–35.CrossRef Mashalla YJ, Sepako E, Setlhare V, Chuma M, Bulang M, Massele AY. Availability of guidelines and policy documents for enhancing performance of practitioners at the Primary Health Care (PHC) facilities in Gaborone, Tlokweng and Mogoditshane, Republic of Botswana. J Public Health Epidemiol. 2016;8(8):127–35.CrossRef
33.
go back to reference Tumwikirize WA, Ogwal-Okeng JW, Vernby O, Anokbonggo WW, Gustafsson LL, Lundborg CS. Access and use of medicines information sources by physicians in public hospitals in Uganda: a cross-sectional survey. Afr Health Sci. 2008;8(4):220–6.PubMedPubMedCentral Tumwikirize WA, Ogwal-Okeng JW, Vernby O, Anokbonggo WW, Gustafsson LL, Lundborg CS. Access and use of medicines information sources by physicians in public hospitals in Uganda: a cross-sectional survey. Afr Health Sci. 2008;8(4):220–6.PubMedPubMedCentral
34.
go back to reference Riaz H, Godman B, Hussain S, Malik F, Mahmood S, Shami A, Bashir S. Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. JPHSR. 2015;6:111–21. Riaz H, Godman B, Hussain S, Malik F, Mahmood S, Shami A, Bashir S. Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. JPHSR. 2015;6:111–21.
35.
go back to reference Fadare JO, Oshikoya KA, Ogunleye OO, Desalu OO, Ferrario A, Enwere OO, et al. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Hosp Pract. 2018;46(2):77–87.CrossRef Fadare JO, Oshikoya KA, Ogunleye OO, Desalu OO, Ferrario A, Enwere OO, et al. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Hosp Pract. 2018;46(2):77–87.CrossRef
36.
go back to reference Civaner M. Sale strategies of pharmaceutical companies in a “pharmerging” country: the problems will not improve if the gaps remain. Health Policy. 2012;106(3):225–32.CrossRefPubMed Civaner M. Sale strategies of pharmaceutical companies in a “pharmerging” country: the problems will not improve if the gaps remain. Health Policy. 2012;106(3):225–32.CrossRefPubMed
37.
go back to reference Vancelik S, Beyhun NE, Acemoglu H, Calikoglu O. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. BMC Public Health. 2007;7:122.CrossRefPubMedPubMedCentral Vancelik S, Beyhun NE, Acemoglu H, Calikoglu O. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. BMC Public Health. 2007;7:122.CrossRefPubMedPubMedCentral
38.
go back to reference Ogunleye OO, Fadare JO, Yinka-Ogunleye AF, Anand Paramadhas BD, Godman B. Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital. Hosp Pract. 2019;47(1):53–8.CrossRef Ogunleye OO, Fadare JO, Yinka-Ogunleye AF, Anand Paramadhas BD, Godman B. Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital. Hosp Pract. 2019;47(1):53–8.CrossRef
39.
go back to reference Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.CrossRefPubMedPubMedCentral Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.CrossRefPubMedPubMedCentral
40.
go back to reference Datta A, Dave D. Effects of physician-directed pharmaceutical promotion on prescription behaviors: longitudinal evidence. Health Econ. 2017;26(4):450–68.CrossRefPubMed Datta A, Dave D. Effects of physician-directed pharmaceutical promotion on prescription behaviors: longitudinal evidence. Health Econ. 2017;26(4):450–68.CrossRefPubMed
41.
go back to reference Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K. Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia. BMC Public Health. 2010;10:743.CrossRefPubMedPubMedCentral Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K. Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia. BMC Public Health. 2010;10:743.CrossRefPubMedPubMedCentral
42.
go back to reference Higuchi M, Okumura J, Aoyama A, Suryawati S, Porter J. Application of standard treatment guidelines in rural community health centres, Timor-Leste. Health Policy Plan. 2012;27(5):396–404.CrossRefPubMed Higuchi M, Okumura J, Aoyama A, Suryawati S, Porter J. Application of standard treatment guidelines in rural community health centres, Timor-Leste. Health Policy Plan. 2012;27(5):396–404.CrossRefPubMed
43.
go back to reference Higuchi M, Okumura J, Aoyama A, Suryawati S, Porter J. Use of medicines and adherence to standard treatment guidelines in rural community health centers, Timor-Leste. Asia Pac J Public Health. 2015;27(2):Np2498-511.CrossRefPubMed Higuchi M, Okumura J, Aoyama A, Suryawati S, Porter J. Use of medicines and adherence to standard treatment guidelines in rural community health centers, Timor-Leste. Asia Pac J Public Health. 2015;27(2):Np2498-511.CrossRefPubMed
44.
go back to reference Eriksen J, Ovesjo ML, Vallin M, Juhasz-Haverinen M, Andersen-Karlsson E, Ateva K, et al. Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’). Eur J Clin Pharmacol. 2018;74(1):131–8.CrossRefPubMed Eriksen J, Ovesjo ML, Vallin M, Juhasz-Haverinen M, Andersen-Karlsson E, Ateva K, et al. Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’). Eur J Clin Pharmacol. 2018;74(1):131–8.CrossRefPubMed
45.
go back to reference Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M, et al. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol. 2013;69(Suppl 1):73–8.CrossRefPubMed Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M, et al. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol. 2013;69(Suppl 1):73–8.CrossRefPubMed
46.
go back to reference Gustafsson LL, Wettermark B, Godman B, Andersen-Karlsson E, Bergman U, Hasselstrom J, et al. The ‘wise list’: a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224–33.CrossRefPubMed Gustafsson LL, Wettermark B, Godman B, Andersen-Karlsson E, Bergman U, Hasselstrom J, et al. The ‘wise list’: a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224–33.CrossRefPubMed
47.
go back to reference Eriksen J, Gustafsson LL, Ateva K, Bastholm-Rahmner P, Ovesjo ML, Jirlow M, et al. High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open. 2017;7(4):e014345.CrossRefPubMedPubMedCentral Eriksen J, Gustafsson LL, Ateva K, Bastholm-Rahmner P, Ovesjo ML, Jirlow M, et al. High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open. 2017;7(4):e014345.CrossRefPubMedPubMedCentral
Metadata
Title
Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications
Authors
Qamar Niaz
Brian Godman
Stephen Campbell
Dan Kibuule
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01056-7

Other articles of this Issue 4/2020

International Journal of Clinical Pharmacy 4/2020 Go to the issue